The earnings follow-up materially improves evidence over the April monitoring baseline, consistent with the deterministic score’s positive directional prior and high thesis-change score. Market validation remains weak: after the October 7 after-close release, LEVI fell from $19.51 at that close to $18.70 on October 9, about 4.2%, while several analysts cut targets. The October 7 trading decline preceded the release and should not be attributed to it. Price weakness and target cuts temper the EPS beat and raised guidance; the apparent refund-driven margin benefit makes Q4 DTC and underlying profitability the decisive checks. No reliable social, options, short-interest or employee measures were supplied.
Price history Analyst revisions